Moderna Vaccine Produced Antibodies in All Patients Tested

Jul.14 — We have some progress on the race for a coronavirus vaccine. Moderna Inc. says its initial safety trials for its drug produced encouraging results, paving the way for final tests within the month. Bloomberg’s Jodi Schneider reports on “Bloomberg Daybreak: Asia.”

About This Source - Bloomberg Markets and Finance

Bloomberg Markets and Finance features news about financial markets from around the world. Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City. It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Bloomberg Books #Ad

Recent from Bloomberg Markets and Finance:

  • Germany Decides: CEO Briefing on the Next Election
  • ‘Bloomberg Surveillance: Early Edition’ Full Show (09/16/2021)
  • Wall Street Week – Full Show (09/17/2021)
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • Cramer: I wouldn’t be a seller of Pfizer, Moderna
  • From Pfizer to Comirnaty: Why are there new names for COVID-19 vaccines in Canada?
  • Moderna COVID-19 vaccine doses to arrive in Adelaide next week | 7NEWS
  • Moderna doses landing on Australian shores within hours | 7NEWS
  • NSW closes in on vaccine targets, Moderna doses arrive in Australia tonight | 9 News Australia
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.